Cargando…
Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations
BACKGROUND: The aim of this study is to explore the treatment and outcome of epileptogenic temporal lobe cavernous malformations (CMs). METHODS: We analyzed retrospectively the profiles of 52 patients diagnosed as temporal lobe CMs associated with epilepsy. Among the 52 cases, 11 underwent a direct...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834007/ https://www.ncbi.nlm.nih.gov/pubmed/25836611 http://dx.doi.org/10.4103/0366-6999.154289 |
_version_ | 1782427429714788352 |
---|---|
author | Shan, Yong-Zhi Fan, Xiao-Tong Meng, Liang An, Yang Xu, Jian-Kun Zhao, Guo-Guang |
author_facet | Shan, Yong-Zhi Fan, Xiao-Tong Meng, Liang An, Yang Xu, Jian-Kun Zhao, Guo-Guang |
author_sort | Shan, Yong-Zhi |
collection | PubMed |
description | BACKGROUND: The aim of this study is to explore the treatment and outcome of epileptogenic temporal lobe cavernous malformations (CMs). METHODS: We analyzed retrospectively the profiles of 52 patients diagnosed as temporal lobe CMs associated with epilepsy. Among the 52 cases, 11 underwent a direct resection of CM along with the adjacent zone of hemosiderin rim without electrocorticogram (ECoG) monitoring while the other 41 cases had operations under the guidance of ECoG. Forty-six patients were treated by lesionectomy + hemosiderin rim while the other six were treated by lesionectomy + hemosiderin rim along with extended epileptogenic zone resection. The locations of lesions, the duration of illness, the manifestation, the excision ranges and the outcomes of postoperative follow-up were analyzed, respectively. RESULTS: All of the 52 patients were treated by microsurgery. There was no neurological deficit through the long-term follow-up. Outcomes of seizure control are as follows: 42 patients (80.8%) belong to Engel Class I, 5 patients (9.6%) belong to Engel Class II, 3 patients (5.8%) belong to Engel Class III and 2 patients (3.8%) belong to Engel Class IV. CONCLUSION: Patients with epilepsy caused by temporal CMs should be treated as early as possible. Resection of the lesion and the surrounding hemosiderin zone is necessary. Moreover, an extended excision of epileptogenic cortex or cerebral lobes is needed to achieve a better prognosis if the ECoG indicates the existence of an extra epilepsy onset origin outside the lesion itself. |
format | Online Article Text |
id | pubmed-4834007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-48340072016-04-29 Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations Shan, Yong-Zhi Fan, Xiao-Tong Meng, Liang An, Yang Xu, Jian-Kun Zhao, Guo-Guang Chin Med J (Engl) Original Article BACKGROUND: The aim of this study is to explore the treatment and outcome of epileptogenic temporal lobe cavernous malformations (CMs). METHODS: We analyzed retrospectively the profiles of 52 patients diagnosed as temporal lobe CMs associated with epilepsy. Among the 52 cases, 11 underwent a direct resection of CM along with the adjacent zone of hemosiderin rim without electrocorticogram (ECoG) monitoring while the other 41 cases had operations under the guidance of ECoG. Forty-six patients were treated by lesionectomy + hemosiderin rim while the other six were treated by lesionectomy + hemosiderin rim along with extended epileptogenic zone resection. The locations of lesions, the duration of illness, the manifestation, the excision ranges and the outcomes of postoperative follow-up were analyzed, respectively. RESULTS: All of the 52 patients were treated by microsurgery. There was no neurological deficit through the long-term follow-up. Outcomes of seizure control are as follows: 42 patients (80.8%) belong to Engel Class I, 5 patients (9.6%) belong to Engel Class II, 3 patients (5.8%) belong to Engel Class III and 2 patients (3.8%) belong to Engel Class IV. CONCLUSION: Patients with epilepsy caused by temporal CMs should be treated as early as possible. Resection of the lesion and the surrounding hemosiderin zone is necessary. Moreover, an extended excision of epileptogenic cortex or cerebral lobes is needed to achieve a better prognosis if the ECoG indicates the existence of an extra epilepsy onset origin outside the lesion itself. Medknow Publications & Media Pvt Ltd 2015-04-05 /pmc/articles/PMC4834007/ /pubmed/25836611 http://dx.doi.org/10.4103/0366-6999.154289 Text en Copyright: © 2015 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Shan, Yong-Zhi Fan, Xiao-Tong Meng, Liang An, Yang Xu, Jian-Kun Zhao, Guo-Guang Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations |
title | Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations |
title_full | Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations |
title_fullStr | Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations |
title_full_unstemmed | Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations |
title_short | Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations |
title_sort | treatment and outcome of epileptogenic temporal cavernous malformations |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834007/ https://www.ncbi.nlm.nih.gov/pubmed/25836611 http://dx.doi.org/10.4103/0366-6999.154289 |
work_keys_str_mv | AT shanyongzhi treatmentandoutcomeofepileptogenictemporalcavernousmalformations AT fanxiaotong treatmentandoutcomeofepileptogenictemporalcavernousmalformations AT mengliang treatmentandoutcomeofepileptogenictemporalcavernousmalformations AT anyang treatmentandoutcomeofepileptogenictemporalcavernousmalformations AT xujiankun treatmentandoutcomeofepileptogenictemporalcavernousmalformations AT zhaoguoguang treatmentandoutcomeofepileptogenictemporalcavernousmalformations |